by Angela C. H. McDonald | Jun 7, 2012
Late in May, the Brampton Fire Department (just outside of Toronto) held a “boot drive” to raise money for Muscular Dystrophy. My boyfriend who happens to be a firefighter tells me that boot drives are fairly common among Canadian fire departments. In fact, they are...
by Roshan Yoganathan | Jun 5, 2012
The last time I blogged here, I introduced the idea of using biomaterials to monitor and sense changes in various physiological environments. Having materials in the body that can do this allows for real-time feedback regarding changes in the body. The use of...
by Lisa Willemse | Jun 1, 2012
Who was it that said “there are no original ideas”? The same person, perhaps, that said “great minds think alike”? Last week, we initiated a stem cell definition challenge via Twitter, asking followers to send their answers in 140 characters or...
by Angela C. H. McDonald | May 29, 2012
Nanotechnology has been a buzzword in the medical technology community for some time. It is defined as the manipulation and use of microscopic structures at the molecular scale, generally 1-100 nanometres in size (1 nanometre is 1 billionth of a metre, which...
by David Kent | May 24, 2012
As a basic researcher in stem cell biology, one of my biggest fears is moving too quickly with cell therapies that involve primitive, still largely mysterious, cell populations. At the World Stem Cells & Regenerative Medicine Congress meeting this week, I felt...
by Stacey Johnson | May 24, 2012
My grandfather was a mathematician and chemical engineer who worked on the Manhattan Project. I dated a chemical engineer for two years. Those two associations are the full breadth of my understanding of this field of science. Apparently I took chemistry in high...
by David Kent | May 22, 2012
You might expect this article to be about creating skin grafts for burn victims or something of that ilk. Instead though, it concerns the complicated process of taking a scientific discovery in regenerative medicine and bringing that discovery through clinical trials...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
by Ubaka Ogbogu | May 18, 2012
The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled...
by Stem Cell Network | May 16, 2012
Welcome to Signals Blog, the new home and new name for the Stem Cell Network Blog. Why the change? After nearly four years, 207 blog posts and several “best of” awards, the SCN Blog finally outgrew its dish, so to speak. Late last year, we began planning...
Comments